Checkpoint Capital L.P. 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Checkpoint Capital L.P. disclosed 16 US equity positions worth $196.5m in its Q4 2024 13F filing. The largest position was ARGX at 29.0% of the reported book, followed by RYTM and PHAT. Against the Q3 2024 filing, it opened 2 new positions, added to 9 and reduced 4 among the top 16 holdings.
What did Checkpoint Capital L.P. own in Q4 2024? Top 16 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ARGX ARGENX SE | Healthcare | 29.0% | $56.9m | 92,500 | 0% | held |
| 2 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 20.7% | $40.8m | 727,982 | 10% | added |
| 3 | PHAT PHATHOM PHARMACEUTICALS INC | 9.4% | $18.5m | 2,274,157 | 51% | added | |
| 4 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 7.5% | $14.8m | 174,769 | -17% | reduced |
| 5 | IRON DISC MEDICINE INC | Healthcare | 6.0% | $11.7m | 185,000 | 624% | added |
| 6 | AVADEL PHARMACEUTICALS PLC | 5.4% | $10.6m | 1,004,790 | -9% | reduced | |
| 7 | RVMD REVOLUTION MEDICINES INC | Healthcare | 4.7% | $9.2m | 210,000 | – | new |
| 8 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 3.6% | $7.1m | 535,494 | 41% | added |
| 9 | TCRX TSCAN THERAPEUTICS INC | 2.7% | $5.3m | 1,755,987 | 113% | added | |
| 10 | CDTX CIDARA THERAPEUTICS INC | 2.6% | $5.1m | 196,949 | 8% | added | |
| 11 | TRVI TREVI THERAPEUTICS INC | Healthcare | 2.3% | $4.5m | 1,084,135 | 334% | added |
| 12 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.7% | $3.4m | 305,387 | 94% | added |
| 13 | SLNOEUR SOLENO THERAPEUTICS INC | 1.6% | $3.1m | 70,027 | 21% | added | |
| 14 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.6% | $3.1m | 77,535 | – | new |
| 15 | ATYR ATYR PHARMA INC | Healthcare | 0.8% | $1.6m | 432,561 | -75% | reduced |
| 16 | CYTK CYTOKINETICS INC | Healthcare | 0.5% | $940.8k | 20,000 | -96% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.